Scholars Central

CommentaryPublished 8 Mar 2018

Clinical Approach to Statin-Induced Adverse Muscle Events: Challenges and Solutions

Authors: Kwame Nuako

Journal of Preventive Medicine

Volume 3 · Issue 2 · Pages 10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statin-associated adverse muscle events play an important role in statin non adherence and discontinuation. Aspects of this clinical challenge including a lack of a uniform definition of statin-induced myalgia, the “nocebo” effect and its’ role in statin-induced adverse muscle events, pre-existing medical and lifestyle factors that can affect statin therapy, and restarting statin use in patients after prior discontinuation of statin therapy due to adverse muscle effects. This paper applies the recommendations of the National Lipid Association’s Statin Muscle Safety Task Force along with other studies to propose solutions for these challenges that statin-induced adverse muscle events present. Future large randomized controlled trials will be necessary for validation of these clinical interventions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Preventive Medicine
  • SubjectPublic Health & Epidemiology
  • BylineArticles whose byline prints “Kwame Nuako”